<DOC>
	<DOCNO>NCT02515201</DOCNO>
	<brief_summary>Clinical trial , aim evaluation use taurolidine heparin prevention bloodstream infection venous catheter child intestinal failure .</brief_summary>
	<brief_title>Heparin Versus Taurolidine Bloodstream Infection Prevention Related Central Venous Catheter Children</brief_title>
	<detailed_description>Will collect data sociodemographics : date birth , hospitalization use ( taurolidine heparin ) , sex , underlie disease associate co-morbidities . About central venous catheter collect : catheter type period , number lumen , date insertion catheter usage time , reason removal catheter insertion site catheter material ( silicone polyurethane ) . Data relate parenteral nutrition also collect : osmolarity parenteral nutrition , infusion time every 24 hour concentration glucose parenteral nutrition bag . It use aseptic handling technique solution , well handle connection central catheter . For preparation administration taurolidine heparin use operation manual make author . Patients divide two group : taurolidine heparin .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Catheter-Related Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Taurolidine</mesh_term>
	<criteria>The population consist patient 30 day life fourteen year old , admit pediatric inpatient unit , intestinal failure receive parenteral nutrition central venous catheter least eight week use forecast . Children exclude associate disease occur frequent use antibiotic , example , cystic fibrosis , primary acquire immunodeficiency . Also exclude child admit accompany responsible family recognition , accompany responsible age 18 year . Children allergic reaction use solution ( taurolidine heparin ) suspend medication receive appropriate treatment . Although child stop use medication , follow accord assessment protocol end study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>